4 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 1 | Terminated 1 |
Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients Imatinib Mesylate intravenous solution, Placebo - ARDS, Acute Respiratory Distress Syndrome | Phase 2 | Terminated | Dr. Jurjan Aman | 67 | 2021-03-14 | 2023-01-23 |
| Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression. UCMSCs, BMMSCs, Placebo - Endothelial Dysfunction, Metabolic Syndrome | Phase 1 / Phase 2 | Terminated | Joshua M Hare | 14 | 2018-04-12 | 2022-11-08 |
| The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance Fish Oil (Omega-3 Fatty Acids) - Endothelial Dysfunction, Insulin Resistance | Phase 2 | Terminated | University of California, San Francisco | 5 | 2011-09-01 | 2013-11-07 |
| Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction 6R-BH4, Placebo - Isolated Systolic Hypertension, Endothelial Dysfunction | Phase 2 | Terminated | Johns Hopkins University | 3 | 2008-12-01 | 2017-08-21 |
Metabolic Syndrome (2) · COVID-19 (1) · Insulin Resistance (1) · Isolated Systolic Hypertension (1) · Peripheral Arterial Disease (1) · Pulmonary Edema (1) · Respiratory Distress Syndrome (1) · Sedentary Behavior (1)
Cardiovascular Diseases (2) · Glucose Metabolism Disorders (2) · Hyperinsulinism (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Behavior (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Essential Hypertension (1) · Hypertension (1) · Infections (1)
Fatty Acids, Omega-3 (1) · Fish Oils (1) · Imatinib Mesylate (1) · sapropterin (1)
Dr. Jurjan Aman (1) · Johns Hopkins University (1) · Joshua M Hare (1) · University of California, San Francisco (1)
United States (3) · Netherlands (1)
Joshua M Hare, MD (1) · Jurjan Aman, Dr. (1) · Marlene Grenon, MD (1)
PMID 35172891, PMID 35976136, PMID 37291677, PMID 37782370, PMID 41109533